logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Gatto, Angelo, Mr.
    Born in March 1973
    Individual (8 offsprings)
    Officer
    icon of calendar 2024-12-03 ~ now
    OF - Director → CIF 0
  • 2
    Mulveen, Aubrey
    Born in November 1968
    Individual (8 offsprings)
    Officer
    icon of calendar 2024-04-02 ~ now
    OF - Director → CIF 0
    Mulveen, Aubrey
    Individual (8 offsprings)
    Officer
    icon of calendar 2025-08-26 ~ now
    OF - Secretary → CIF 0
  • 3
    HERRIOT PHARMA UK HOLDCO LIMITED
    icon of address30, Broadwick Street, London, United Kingdom
    Active Corporate (3 parents, 5 offsprings)
    Person with significant control
    icon of calendar 2024-04-03 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 8
  • 1
    Burke, Ulick
    Director born in June 1972
    Individual (3 offsprings)
    Officer
    icon of calendar 2019-12-01 ~ 2024-04-02
    OF - Director → CIF 0
  • 2
    Burke, Joan Marie
    Director born in November 1961
    Individual (2 offsprings)
    Officer
    icon of calendar 2019-11-26 ~ 2024-04-02
    OF - Director → CIF 0
  • 3
    Walsh, Kara Ann
    Company Director born in November 1970
    Individual
    Officer
    icon of calendar 2024-04-02 ~ 2025-08-26
    OF - Director → CIF 0
    Walsh, Kara Ann
    Individual
    Officer
    icon of calendar 2024-04-02 ~ 2025-08-26
    OF - Secretary → CIF 0
  • 4
    Burke, Michael Hilary
    Director born in October 1947
    Individual (4 offsprings)
    Officer
    icon of calendar 2007-04-05 ~ 2024-04-02
    OF - Director → CIF 0
    Burke, Michael Hilary
    Individual (4 offsprings)
    Officer
    icon of calendar 2019-12-01 ~ 2024-04-02
    OF - Secretary → CIF 0
    Mr Michael Hilary Burke
    Born in October 1947
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2024-04-03
    PE - Ownership of shares – 75% or moreCIF 0
  • 5
    Mccoy, Chanelle
    Director born in June 1976
    Individual (10 offsprings)
    Officer
    icon of calendar 2007-04-05 ~ 2019-12-01
    OF - Director → CIF 0
    Mccoy, Chanelle, Lady
    Director
    Individual (10 offsprings)
    Officer
    icon of calendar 2007-04-05 ~ 2019-12-01
    OF - Secretary → CIF 0
  • 6
    Kavanagh, Sean
    Director born in May 1963
    Individual
    Officer
    icon of calendar 2007-04-04 ~ 2007-04-05
    OF - Director → CIF 0
  • 7
    Lynch, Gemma
    Director born in April 1965
    Individual
    Officer
    icon of calendar 2022-10-27 ~ 2023-02-23
    OF - Director → CIF 0
  • 8
    AEROPM LIMITED
    icon of address22 Northumberland Road, Ballsbridge, Dublin 4, Republic Of Ireland
    Dissolved Corporate (2 parents, 9 offsprings)
    Officer
    2007-04-04 ~ 2007-04-05
    PE - Secretary → CIF 0
parent relation
Company in focus

CHANELLE VET U.K. LIMITED

Previous names
CHANELLE VETERINARY (U.K.) LIMITED - 2007-09-28
CHANELLE PHARMACEUTICALS (UK) LIMITED - 2007-11-23
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Turnover/Revenue
7,077,188 GBP2023-05-01 ~ 2024-04-30
6,016,111 GBP2022-05-01 ~ 2023-04-30
Cost of Sales
-4,377,909 GBP2023-05-01 ~ 2024-04-30
-3,738,579 GBP2022-05-01 ~ 2023-04-30
Gross Profit/Loss
2,699,279 GBP2023-05-01 ~ 2024-04-30
2,277,532 GBP2022-05-01 ~ 2023-04-30
Administrative Expenses
-2,341,562 GBP2023-05-01 ~ 2024-04-30
-2,066,722 GBP2022-05-01 ~ 2023-04-30
Operating Profit/Loss
357,717 GBP2023-05-01 ~ 2024-04-30
210,810 GBP2022-05-01 ~ 2023-04-30
Interest Payable/Similar Charges (Finance Costs)
-8,630 GBP2023-05-01 ~ 2024-04-30
-6,509 GBP2022-05-01 ~ 2023-04-30
Profit/Loss on Ordinary Activities Before Tax
349,087 GBP2023-05-01 ~ 2024-04-30
204,301 GBP2022-05-01 ~ 2023-04-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-88,600 GBP2023-05-01 ~ 2024-04-30
-40,304 GBP2022-05-01 ~ 2023-04-30
Intangible Assets
0 GBP2024-04-30
0 GBP2023-04-30
Property, Plant & Equipment
0 GBP2024-04-30
0 GBP2023-04-30
Fixed Assets - Investments
0 GBP2024-04-30
0 GBP2023-04-30
Fixed Assets
0 GBP2024-04-30
0 GBP2023-04-30
Total Inventories
1,889,780 GBP2024-04-30
2,311,985 GBP2023-04-30
Debtors
2,265,353 GBP2024-04-30
2,809,232 GBP2023-04-30
Cash at bank and in hand
1,549,035 GBP2024-04-30
822,545 GBP2023-04-30
Current Assets
5,704,168 GBP2024-04-30
5,943,762 GBP2023-04-30
Net Current Assets/Liabilities
1,307,492 GBP2024-04-30
1,047,005 GBP2023-04-30
Total Assets Less Current Liabilities
1,307,492 GBP2024-04-30
1,047,005 GBP2023-04-30
Net Assets/Liabilities
1,307,492 GBP2024-04-30
1,047,005 GBP2023-04-30
Equity
Called up share capital
4 GBP2024-04-30
4 GBP2023-04-30
Retained earnings (accumulated losses)
1,307,488 GBP2024-04-30
1,047,001 GBP2023-04-30
Equity
1,307,492 GBP2024-04-30
1,047,005 GBP2023-04-30
Average Number of Employees
182023-05-01 ~ 2024-04-30
182022-05-01 ~ 2023-04-30
Other types of inventories not specified separately
1,889,780 GBP2024-04-30
2,311,985 GBP2023-04-30
Trade Debtors/Trade Receivables
1,809,153 GBP2024-04-30
1,820,628 GBP2023-04-30
Prepayments/Accrued Income
63,817 GBP2024-04-30
12,789 GBP2023-04-30
Other Debtors
392,383 GBP2024-04-30
975,815 GBP2023-04-30
Trade Creditors/Trade Payables
Amounts falling due within one year
540,553 GBP2024-04-30
412,458 GBP2023-04-30
Taxation/Social Security Payable
Amounts falling due within one year
259,307 GBP2024-04-30
375,610 GBP2023-04-30
Accrued Liabilities/Deferred Income
Amounts falling due within one year
1,519,485 GBP2024-04-30
1,635,673 GBP2023-04-30
Other Creditors
Amounts falling due within one year
2,077,331 GBP2024-04-30
2,473,016 GBP2023-04-30

  • CHANELLE VET U.K. LIMITED
    Info
    CHANELLE VETERINARY (U.K.) LIMITED - 2007-09-28
    CHANELLE PHARMACEUTICALS (UK) LIMITED - 2007-09-28
    Registered number 06203599
    icon of address483 Green Lanes, London N13 4BS
    PRIVATE LIMITED COMPANY incorporated on 2007-04-04 (18 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-09
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.